Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
03/2007
03/08/2007US20070053877 Methods of treating idiopathic pulmonary fibrosis
03/08/2007US20070053875 Homogeneous preparations of il-28 and il-29
03/08/2007US20070053874 Methods for treating viral infection using il-28 and il-29
03/08/2007US20070053873 Canine tumor treatment method, pharmaceutical formulation applied thereto, and method of cryogenically preserving cells used therewith
03/08/2007US20070053872 Treatment of wounds using il-17b
03/08/2007US20070053871 Sterile; darbepoetin or erythropoietin where glycerol, trimethylamine N-oxide or proline mitigates the destabilizing effect of preservative benzyl alcohol or benzalkonium chloride; able to withdraw several doses from a single vial, that is a multi-dose product
03/08/2007US20070053870 Polysaccharide-functionalized nanoparticle, drug delivery system for controlled release comprising the same and preparation method thereof
03/08/2007US20070053864 Poly(potassium and sodiumstyrene sulfonate) its manufacture and its uses
03/08/2007US20070053852 Lipidic protein-transfer systems and cosmetic/dermatological use thereof
03/08/2007US20070053845 Nanocell drug delivery system
03/08/2007US20070053838 Comprises therapeutically effective amounts of at least one chemotherapeutic agent along with the biotherapeutic endogenous pentapeptide Met-enkephalin (opioid growth factor); cancer
03/08/2007DE102005041616A1 Melanom-assoziierte MHC Klasse I assoziierte Oligopeptide und deren Verwendungen Melanoma-associated MHC class I-associated oligopeptides and their uses
03/08/2007CA2625940A1 Use of histogranin and histogranin-like compounds as inhibitors of p2x7 receptor function and as anti-arthritic agents
03/08/2007CA2625674A1 Methods and compositions for prevention and treatment of diabetic and aged skin
03/08/2007CA2621226A1 Methods for using and identifying modulators of delta-like 4
03/08/2007CA2621153A1 Method of repairing meniscal tears using a collogen membrane material
03/08/2007CA2621083A1 Immunomodulating tumor necrosis factor receptor 25 (tnfr25) agonists, antagonists and immunotoxins
03/08/2007CA2620886A1 Cellular libraries of peptide sequences (clips) and methods of using the same
03/08/2007CA2620809A1 Prophylactic and therapeutic agents and uses therefor
03/08/2007CA2620774A1 Streptococcus suis polypeptides and polynucleotides encoding same and their use in vaccinal and diagnostic applications
03/08/2007CA2620729A1 Modified chaperonin 10
03/08/2007CA2620638A1 Liquid formulations of pegylated growth hormone
03/08/2007CA2620577A1 Peptide mimics of melanocyte stimulating hormone
03/08/2007CA2616479A1 Treatment of optic neuritis
03/07/2007EP1760154A2 sequences from natural or synthetic retroelements having the function of allowing the insertion of nucleotide sequences in a eukaryotic cell
03/07/2007EP1760153A2 Adenovirus/alphavirus hybrid vector for the effective administration and expression of therapeutic genes in tumour cells
03/07/2007EP1760151A1 An improved method for the production and purification of adenoviral vectors
03/07/2007EP1760090A1 Regulatory/unfolding peptides of ezrin
03/07/2007EP1760089A1 Tumor-associated peptides binding to human leukocyte antigen (HLA) class I or II molecules and related anti-cancer vaccine
03/07/2007EP1759734A2 Aromatase inhibition to enhance assisted reproduction
03/07/2007EP1759718A1 Tissue closing preparation
03/07/2007EP1759710A1 Remedy or preventive for arthritis
03/07/2007EP1759709A1 Humanized antibodies against leukocyte adhesion molecule VLA-4
03/07/2007EP1759708A1 IFN-beta for treating bone disorder related to cancer
03/07/2007EP1759707A2 Canine tumor treatment method, pharmaceutical formulation applied thereto and method of cryogenically preserving cells used therewith
03/07/2007EP1759700A1 Use of a PDE5 inhibitor for treating and preventing hypopigmentary disorders
03/07/2007EP1759203A2 Methods and means for treatment of osteoarthritis
03/07/2007EP1759199A2 Insulin-independent, bone morphogenetic protein (bmp)-mediated uptake of blood glucose by peripheral cells and tissues
03/07/2007EP1759013A2 Identification of surface-associated antigens for tumor diagnosis and therapy
03/07/2007EP1759007A2 Method of complexing a protein by the use of a dispersed system and proteins thereof
03/07/2007EP1759001A1 Bone delivery conjugates and method of using same to target proteins to bone
03/07/2007EP1758990A2 Method for ameliorating an inflammatory skin condition
03/07/2007EP1758935A1 High affinity telomerase t cell receptors
03/07/2007EP1758934A2 Cospeptin, cosmedin and their uses
03/07/2007EP1758932A2 Metastin derivatives and use thereof
03/07/2007EP1758931A1 Peptides derived from decorin leucine rich repeats and uses thereof
03/07/2007EP1758930A2 OsK1 DERIVATIVES
03/07/2007EP1758927A2 Amidated parathyroid hormone fragments and uses thereof
03/07/2007EP1758926A2 Methods for treating and diagnosing cancer with wnt inhibitory factor-1 (wif-1)
03/07/2007EP1758925A2 Recombinant icosahedral virus like particle production in pseudomonads
03/07/2007EP1758923A1 Peptide substance restoring myocardium function
03/07/2007EP1758922A1 Peptide substance restoring function of respiratory organs
03/07/2007EP1758921A2 Compounds for proteasome enzyme inhibition
03/07/2007EP1758920A1 Bacterial efflux pump inhibitors and methods of treating bacterial infections
03/07/2007EP1758915A2 Composition and method for inhibiting platelet aggregation
03/07/2007EP1758640A2 Inhibition of hiv-1 replication by disruption of the processing of the viral capsid-spacer peptide 1 protein
03/07/2007EP1758612A2 Composition comprising intercalated functional-active organic compounds
03/07/2007EP1758611A2 Use of liver-selective glucokinase activators
03/07/2007EP1758610A1 Methods of treating cancer using il-21 and monoclonal antibody therapy
03/07/2007EP1758608A2 Conjugates of hydroxyethyl starch and erythropoietin
03/07/2007EP1758607A1 Medicament comprising ptx3, alone or in combination with tsg-6, for treating degenerative diseases of cartilage and bone and treating female infertility
03/07/2007EP1758606A1 Novel use of peptide compounds for treating essential tremor and other tremor syndromes
03/07/2007EP1758605A2 Prouroguanylin as therapeutic and diagnostic agents
03/07/2007EP1758601A1 Treatment with cisplatin and an egfr-inhibitor
03/07/2007EP1758595A2 Use of lipid conjugates in the treatment of diseases
03/07/2007EP1758569A2 Guanylhydrazone salts, compositions, processes of making and methods of using
03/07/2007EP1758553A1 Pharmaceutical compositions comprising polyethylene glycol having a molecular weight of less than 600 daltons
03/07/2007EP1680139B1 Use of somatostatin or one of the analogs thereof for producing a medicament serving to regulate the ovarian follicular reserve in non-menopausal women
03/07/2007EP1646646B1 Antibiotic 107891, its factors a1 and a2, pharmaceutically acceptable salts and compositions, and use thereof.
03/07/2007EP1551447A4 Anti-addl antibodies and uses thereof
03/07/2007EP1531842A4 Regulation of cell growth by muc1
03/07/2007EP1490097B1 Use of botulinum toxin for treating cardiovascular diseases
03/07/2007EP1478355B1 Antitumor compositions containing taxane derivatives
03/07/2007EP1352061B9 Method for inhibiting the expression of a target gene
03/07/2007EP1351704B1 Storage stable powder compositions of interleukin-4 receptor
03/07/2007EP1333840B1 M. tuberculosis chaperonin 60.1 and uses thereof
03/07/2007EP1279677B1 Gd3-mimetic peptides
03/07/2007EP1266005B1 Regulation of human lipoxin a4 receptor-like protein
03/07/2007EP1261622B1 Purified recombinant hlh having a specific bioactivity and process for purification thereof
03/07/2007EP1228202B1 Antisense compositions and cancer-treatment methods
03/07/2007EP1210445B1 Recombinant microorganisms
03/07/2007EP1131348B1 Regulatory/unfolding peptides of ezrin
03/07/2007EP1044013B1 Use of a phosphatidylserine/polypeptide conjugate for inducing autoimmunity in the treatment of cancers
03/07/2007EP1017817B1 Mutants of thyroid stimulating hormone
03/07/2007EP1009752B1 Novel molecules of the tango-77 related protein family and uses thereof
03/07/2007EP1003784B1 Novel peptides and polypeptides useful for regenerating the nervous system
03/07/2007EP1001970B1 Dipeptide derivatives as growth hormone secretagogues
03/07/2007EP0946713B1 Method for in vitro preconditioning of myoblasts before transplantation
03/07/2007EP0838221B1 Lyophilized hgf preparations
03/07/2007EP0585242B2 Wound healing
03/07/2007CN1926242A Sialytated glycoproteins-process conditions and an efficient method for their production
03/07/2007CN1926237A Heterodimeric follicle stimulating hormone-Fc (FSH-Fc) fusion proteins for the treatment of infertility
03/07/2007CN1926154A EC SOD and cell transducing EC SOD and use thereof
03/07/2007CN1926151A Treating or preventing extracellular matrix build-up
03/07/2007CN1926147A Nogo受体拮抗剂 Nogo receptor antagonist
03/07/2007CN1925872A Method of preventing ultraviolet ray-induced apoptosis
03/07/2007CN1925868A Paraoxonase-containing pharmaceutical preparation
03/07/2007CN1925867A Pharmaceutical formulations for the sustained release of interleukins and therapeutic applications thereof
03/07/2007CN1925866A Treatment of bacterial infections
03/07/2007CN1925865A Pharmaceutical compositions for prevention of overdose or abuse
1 ... 1131 1132 1133 1134 1135 1136 1137 1138 1139 1140 1141 1142 1143 1144 1145 1146 1147 1148 1149 1150 1151 ... 3163